Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Listening to Provenge--what a costly cancer treatment says about future Medicare policy.

× No keyword cloud information.

16 in total

1. Recent advances in the therapy of castration-resistant prostate cancer: the price of progress.

Authors: Dhwanishiva Vasani; David Y Josephson; Courtney Carmichael; Oliver Sartor; Sumanta Kumar Pal
Journal: Maturitas Date: 2011-08-09 Impact factor: 4.342

Review 2. A pharmacologic perspective on newly emerging T-cell manipulation technologies.

Authors: Dominic Smethurst
Journal: Br J Clin Pharmacol Date: 2013-08 Impact factor: 4.335

3. The changing landscape in the treatment of metastatic castration-resistant prostate cancer.

Authors: Joelle El-Amm; Jeanny B Aragon-Ching
Journal: Ther Adv Med Oncol Date: 2013-01 Impact factor: 8.168

4. Do changes in drug coverage policy point to an increased role for cost-effectiveness analysis in the USA?

Authors: James D Chambers
Journal: Pharmacoeconomics Date: 2014-08 Impact factor: 4.981

5. Hot-Spotters Aren't "The Problem"...But They Are Emblematic of the Failure of U.S. Healthcare.

Authors: Hemal K Kanzaria; Jerome R Hoffman
Journal: J Gen Intern Med Date: 2017-01 Impact factor: 5.128

6. Recalibrating Health Technology Assessment Methods for Cell and Gene Therapies.

Authors: Aris Angelis; Huseyin Naci; Allan Hackshaw
Journal: Pharmacoeconomics Date: 2020-12 Impact factor: 4.981

7. Whole blood cells loaded with messenger RNA as an anti-tumor vaccine.

Authors: Kyle K L Phua; David Boczkowski; Jens Dannull; Scott Pruitt; Kam W Leong; Smita K Nair
Journal: Adv Healthc Mater Date: 2013-12-16 Impact factor: 9.933

8. Direct loading of CTL epitopes onto MHC class I complexes on dendritic cell surface in vivo.

Authors: Peng Wang; Shuyun Dong; Peng Zhao; Xiao He; Mingnan Chen
Journal: Biomaterials Date: 2018-08-06 Impact factor: 12.479

9. Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments.

Authors: Shilpa Gupta; Estrella Carballido; Mayer Fishman
Journal: Onco Targets Ther Date: 2011-06-29 Impact factor: 4.147

10. The timing of drug funding announcements relative to elections: a case study involving dementia medications.

Authors: Sudeep S Gill; Neeraj Gupta; Chaim M Bell; Paula A Rochon; Peter C Austin; Andreas Laupacis
Journal: PLoS One Date: 2013-02-27 Impact factor: 3.240